|
Re: Additional Exempt Distribution
|
2
|
Zenith Epigenetics
|
Oct 30, 2023 09:22AM
|
|
Re: The crick didn’t rise, here’s the presentation, finally!
|
|
Zenith Epigenetics
|
Oct 29, 2023 10:10AM
|
|
October 24, 2023 How SARS-CoV-2 contributes to heart attacks and strokes
|
3
|
Resverlogix Corp.
|
Oct 29, 2023 08:36AM
|
|
Re: The crick didn’t rise, here’s the presentation, finally!
|
1
|
Zenith Epigenetics
|
Oct 28, 2023 04:13PM
|
|
Re: Notice anything different about #11
|
2
|
Zenith Epigenetics
|
Oct 27, 2023 09:03AM
|
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
|
Resverlogix Corp.
|
Oct 26, 2023 07:18PM
|
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
4
|
Resverlogix Corp.
|
Oct 26, 2023 12:54PM
|
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
3
|
Zenith Epigenetics
|
Oct 26, 2023 12:41PM
|
|
Re: Zenith Epigenetics Ltd. Announces Collaboration with Cencora on ZEN-3694
|
3
|
Resverlogix Corp.
|
Oct 26, 2023 10:22AM
|
|
ACCORDING TO "GlobalData" https://www.globalda...
|
3
|
Resverlogix Corp.
|
Oct 26, 2023 08:02AM
|
|
Additional Exempt Distribution
|
2
|
Zenith Epigenetics
|
Oct 23, 2023 05:17PM
|
|
Re: Vote reminder
|
1
|
Zenith Epigenetics
|
Oct 21, 2023 11:04AM
|
|
Re: Long time that we’ve seen a post!
|
3
|
Resverlogix Corp.
|
Oct 20, 2023 05:59AM
|
|
Re: Additional Exempt Distributions
|
1
|
Zenith Epigenetics
|
Oct 14, 2023 05:01AM
|
|
Re: Additional Exempt Distributions
|
2
|
Zenith Epigenetics
|
Oct 09, 2023 03:36PM
|
|
Re: Vote - please
|
1
|
Zenith Epigenetics
|
Oct 05, 2023 07:14AM
|
|
Re: Vote - please
|
|
Zenith Epigenetics
|
Oct 04, 2023 07:10PM
|
|
Re: Vote - please
|
1
|
Zenith Epigenetics
|
Oct 04, 2023 02:10PM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
3
|
Resverlogix Corp.
|
Oct 04, 2023 11:41AM
|
|
Re: Resverlogix Publishes on Apabetalone's Potential for the Treatment of FSHD, the Third Most Common Muscular Dystrophy
|
5
|
Resverlogix Corp.
|
Oct 04, 2023 09:03AM
|
